全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...

Evaluation of a Low-Threshold/High-Tolerance Methadone Maintenance Treatment Clinic in Saint John, New Brunswick, Canada: One Year Retention Rate and Illicit Drug Use

DOI: 10.1155/2013/753409

Full-Text   Cite this paper   Add to My Lib

Abstract:

Objective. To report the one-year retention rate and the prevalence of illicit opioid use and cocaine use in the Low-Threshold/High-Tolerance (LTHT) methadone maintenance treatment (MMT) clinic located in Saint John, New Brunswick, Canada. Methods. A description of the LTHT MMT clinic is provided. The one-year retention rate was determined by collecting data on patients who enrolled in the LTHT MMT clinic between August 04, 2009 and August 04, 2010. The prevalence of illicit drug use was determined using a randomly selected retrospective cohort of 84 participants. For each participant the results of six consecutive urine tests for the most recent three months were compared to the results of the first six consecutive urine tests after program entry. Results. The one-year retention rate was 95%, 67% of the cohort achieved abstinence from illicit opioids and an additional 13% abstained from cocaine use. Conclusion. The novel feature of the LTHT MMT clinic is that patients are not denied methadone because of lack of ancillary services. Traditional comprehensive MMT programs invest the majority of financial resources in ancillary services that support the biopsychosocial model, whereas the LTHT approach utilizes a medical model and directs resources at medical management. 1. Introduction Most Canadian methadone maintenance treatment (MMT) programs have limited treatment capacity, hundreds of people on wait-lists and wait-times that exceed 6–12 months [1]. The result is that many people, who are motivated to seek treatment for their addiction, remain untreated. In Canada, the provision of MMT is regulated by Health Canada’s guidelines, with each province and/or territory having the option of developing their own [2]. A review of the Federal Guidelines and those of seven provinces demonstrate that each adheres to the biopsychosocial model of MMT and require, among other things, the provision of psychosocial counseling, random urine testing, and mechanisms for the involuntary discharge of patients [3–9]. This paper will report the evaluation results of the low-threshold/high-tolerance (LTHT) MMT clinic in Saint John, New Brunswick, Canada. The LTHT approach is novel because it utilizes a medical model rather than the traditional biopsychosocial model that predominates in Canada. This model incorporates recommendations of the Government of Canada “best practices” document with the foundational premise that the provision of MMT should not be contingent on the availability of resources for psychosocial treatment [10, 11]. The “low-threshold” aspect refers to the

References

[1]  J. Luce and C. Strike, A Cross-Canada Scan of Methadone Maintenance Developments, 2011.
[2]  Health and Welfare Canada, The Use of Opioids in the Management of Opioid Dependence, Minister of Supply and Services Canada, 1992.
[3]  College of Physicians & Surgeons of Alberta, Standards & Guidelines For Methadone Maintenance Treatment in Alberta, College of Physicians an Surgeons of Alberta, 2005.
[4]  College of Physicians and Surgeons of British Columbia, Methadone Maintenance Handbook, College of Physicians and Surgeons of British Columbia, 2009.
[5]  College of Physicians & Surgeons of Nova Scotia, Methadone Maintenance Treatment Handbook, College of Physicians & Surgeons of Nova Scotia, 2012.
[6]  College of Physicians & Surgeons of Ontario, Methadone Maintenance Treatment Program Standards and Clinical Guidelines, College of Physicians and Surgeons of Ontario, 4th edition, 2011.
[7]  College of Physicians and Surgeons of Saskatchewan, Saskatchewan Methadone Guidelines for the Treatment of Opiate Addiction, College of Physicians and Surgeons and Saskatchewan Health, 2008.
[8]  New Brunswick Addiction Services, MMT Maintenance Treatment Polices and Procedures: New Beginnings, 2009.
[9]  Collège des Médecins du Québec, The Use of Methadone in the Treatment of Opiate Addiction: Clinical Practice Guidelines, College de Medecins du Quebec, 2000.
[10]  Jamieson, Beals, Lalond and Associates, Inc, Best Practices Methadone Maintenance Treatment, Minister of Public Works and Government Services Canada, 2002.
[11]  L. Amato, S. Minozzi, M. Davoli, S. Vecchi, M. M. Ferri, and S. Mayet, “Psychosocial combined with agonist maintenance treatments versus agonist maintenance treatments alone for treatment of opioid dependence,” Cochrane Database of Systematic Reviews, no. 4, Article ID CD004147, 2008.
[12]  J. F. Anderson and L. D. Warren, “Client retention in the British Columbia methadone program, 1996–1999,” Canadian Journal of Public Health, vol. 95, no. 2, pp. 104–109, 2004.
[13]  B. Nosyk, D. C. Marsh, H. Sun, M. T. Schechter, and A. H. Anis, “Trends in methadone maintenance treatment participation, retention, and compliance to dosing guidelines in British Columbia, Canada: 1996–2006,” Journal of Substance Abuse Treatment, vol. 39, no. 1, pp. 22–31, 2010.
[14]  B. Fischer, J. Rehm, S. Brissette et al., “Illicit opioid use in Canada: comparing social, health, and drug use characteristics of untreated users in five cities (OPICAN Study),” Journal of Urban Health, vol. 82, no. 2, pp. 250–266, 2005.
[15]  E. Oviedo-Joekes, S. Brissette, D. C. Marsh et al., “Diacetylmorphine versus methadone for the treatment of opioid addiction,” New England Journal of Medicine, vol. 361, no. 8, pp. 777–786, 2009.
[16]  C. J. Strike, W. Gnam, K. Urbanoski, B. Fischer, D. C. Marsh, and M. Millson, “Factors predicting 2-year retention in methadone maintenance treatment for opioid dependence,” Addictive Behaviors, vol. 30, no. 5, pp. 1025–1028, 2005.
[17]  J. Mendelson, K. Flower, M. J. Pletcher, and G. P. Galloway, “Addiction to prescription opioids: characteristics of the emerging epidemic and treatment with buprenorphine,” Experimental and Clinical Psychopharmacology, vol. 16, no. 5, pp. 435–441, 2008.
[18]  V. P. Dole, M. E. Nyswander, and M. J. Kreek, “Narcotic blockade,” Archives of Internal Medicine, vol. 118, no. 4, pp. 304–309, 1966.
[19]  J. R. M. Caplehorn, M. S. Y. N. Dalton, M. C. Cluff, and A. M. Petrenas, “Retention in methadone maintenance and heroin addicts' risk of death,” Addiction, vol. 89, no. 2, pp. 203–209, 1994.
[20]  L. A. Marsch, “The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis,” Addiction, vol. 93, no. 4, pp. 515–532, 1998.
[21]  S. M. Kelly, K. E. O'Grady, S. G. Mitchell, B. S. Brown, and R. P. Schwartz, “Predictors of methadone treatment retention from a multi-site study: a survival analysis,” Drug and Alcohol Dependence, vol. 117, no. 2-3, pp. 170–175, 2011.
[22]  I. Maremmani, P. P. Pani, A. Mellini et al., “Alcohol and cocaine use and abuse among opioid addicts engaged in a Methadone Maintenance Treatment Program,” Journal of Addictive Diseases, vol. 26, no. 1, pp. 61–70, 2007.
[23]  S. M. Stine, M. Freeman, B. Burns, D. S. Charney, and T. R. Kosten, “Effect of methadone dose on cocaine abuse in a methadone program,” American Journal on Addictions, vol. 1, no. 4, pp. 294–298, 1992.

Full-Text

comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413